Peroxisome proliferator-activated receptor-α regulates fatty acid utilization in primary human skeletal muscle cells

Diabetes

Volumn 51, Issue 4, 2002, Pages 901-909

  Muoio, Deborah M ^a,b,d   Way, James M ^c   Tanner, Charles J ^b   Winegar, Deborah A ^c   Kliewer, Steven A ^c   Houmard, Joseph A ^b   Kraus, William E ^a   Lynis Dohm, G ^b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b EAST CAROLINA UNIVERSITY   (United States)

^c GLAXOSMITHKLINE   (United States)

^d DUKE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON 14; CARBOXYLYASE; CARNITINE PALMITOYLTRANSFERASE; ETOMOXIR; FATTY ACID; GLYCEROLIPID; LIPID; MALONYL COENZYME A; MESSENGER RNA; MITOCHONDRIAL ENZYME; OLEIC ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PHOSPHOTRANSFERASE; PYRUVATE DEHYDROGENASE; TRIACYLGLYCEROL;

ARTICLE; CATABOLISM; CELL DIFFERENTIATION; CONTROLLED STUDY; DOSE RESPONSE; ESTERIFICATION; FATTY ACID METABOLISM; FATTY ACID OXIDATION; GENE EXPRESSION; HOMEOSTASIS; HUMAN; HUMAN CELL; LIPOGENESIS; MUSCLE CELL; MYOTUBE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; SKELETAL MUSCLE;

EID: 0036224157     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.51.4.901     Document Type: Article

References (39)

1. Differential expression of peroxisome proliferator-activated receptors (PPARs): Tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat
2. The role of the peroxisome proliferator-activated receptor alpha (PPARalpha) in the control of cardiac lipid metabolism
3. A critical role for the peroxisome proliferator-activated receptor alpha (PPARalpha) in the cellular fasting response: The PPARalpha-null mouse as a model of fatty acid oxidation disorders
4. Peroxisome proliferator-activated receptor-alpha activators regulate genes governing lipoprotein metabolism, vascular inflammation and atherosclerosis
5. Peroxisome proliferator-activated receptor (PPAR)-α activation lowers muscle lipids and improves insulin sensitivity in high fat-fed rats: Comparison with PPAR-γ activation
6. Peroxisome proliferator-activated receptor (PPAR) alpha activation and its consequences in humans
7. Activators of peroxisome proliferator-activated receptor-α induce the expression of the uncoupling protein-3 gene in skeletal muscle: A potential mechanism for the lipid intake-dependent activation of uncoupling protein-3 gene expression at birth
8. A potent PPARalpha agonist stimulates mitochondrial fatty acid beta-oxidation in liver and skeletal muscle
9. Mechanism responsible for inactivation of skeletal muscle pyruvate dehydrogenase complex in starvation and diabetes
10. Regulation of cardiac and skeletal muscle malonyl-CoA decarboxylase by fatty acids
11. Monitoring of PPAR alpha protein expression in human tissue by the use of PPAR alpha-specific MAbs
12. Identification of a subtype selective human PPARalpha agonist through parallel-array synthesis
13. Glycogen synthase activity is reduced in cultured skeletal muscle cells of non-insulin-dependent diabetes mellitus subjects. Biochemical and molecular mechanisms
14. Lipid oxidation is reduced in obese human skeletal muscle
15. A rapid method of total lipid extraction and purification
16. Comprehensive messenger ribonucleic acid profiling reveals that peroxisome proliferator-activated receptor gamma activation has coordinate effects on gene expression in multiple insulin-sensitive tissues
17. Up-regulation of uncoupling protein 3 by thyroid hormone, peroxisome proliferator-activated receptor ligands and 9-cis retinoic acid in L6 myotubes
18. A gender-related defect in lipid metabolism and glucose homeostasis in peroxisome proliferator-activated receptor alpha-deficient mice
19. Improved insulin sensitivity by bezafibrate in rats: Relationship to fatty acid composition of skeletal-muscle triglycerides
20. Transcriptional regulation of gene expression in human skeletal muscle during recovery from exercise
21. Fibre-type specific modification of the activity and regulation of skeletal muscle pyruvate dehydrogenase kinase (PDK) by prolonged starvation and refeeding is associated with targeted regulation of PDK isoenzyme 4 expression
22. Interactive regulation of the pyruvate dehydrogenase complex and the carnitine palmitoyltransferase system
23. Evidence for existence of tissue-specific regulation of the mammalian pyruvate dehydrogenase complex
24. Starvation increases the amount of pyruvate dehydrogenase kinase in several mammalian tissues
25. Human skeletal muscle carnitine patmitoyltransferase I activity determined in isolated intact mitochondria
26. Regulation of fatty acid oxidation by acetyl-CoA generated from glucose utilization in isolated myocytes
27. Physiological and nutritional regulation of enzymes of triacylglycerol synthesis
28. Lipoprotein secretion and triglyceride stores in the heart
29. Cellular mechanisms of insulin resistance
30. Diet-induced muscle insulin resistance in rats is ameliorated by acute dietary lipid withdrawal or a single bout of exercise: Parallel relationship between insulin stimulation of glucose uptake and suppression of long-chain fatty acyl-CoA
31. Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: A 1H NMR spectroscopy study
32. Intramyocellular triglyceride content is a determinant of in vivo insulin resistance in humans: A 1H-13C nuclear magnetic resonance spectroscopy assessment in offspring of type 2 diabetic parents
33. Fuel selection in human skeletal muscle in insulin resistance: A reexamination
34. Markers of capacity to utilize fatty acids in human skeletal muscle: Relation to insulin resistance and obesity and effects of weight loss
35. Mechanisms modifying glucose oxidation in diabetes mellitus
36. Peroxisome proliferator-activated receptor alpha activators improve insulin sensitivity and reduce adiposity
37. Improvement of glucose tolerance in NIDDM by clofibrate: Randomized double-blind study
38. Effects of gemfibrozil on insulin sensitivity and on haemostatic variables in hypertriglyceridemic patients
39. Decreasing triglyceride by gemfibrozil therapy does not affect the glucoregulatory or antilipolytic effect of insulin in nondiabetic subjects with mild hypertriglyceridemia